Peter Gregersen

Innovation in the Age of Coronavirus

The evolving COVID-19 pandemic is reshaping the world around us, and myriad Long Island forces – large and small, corporate and nonprofit, industrial and academic – have risen to the challenge. Innovate Long Island presents Innovation in the Age of Coronavirus as a real-time journal of this region’s resourceful response to the greatest global challenge since World War II. Stay healthy, dear readers.     Albany’s color guard races to pace micro-clusters (Oct. 21) With…


Feinstein ‘risk index’ could get the jump on lupus

By GREGORY ZELLER // A complex research effort led by top Feinstein Institute scientists has opened the door to a wide range of early-intervention protocols for the dreaded disease lupus. A Feinstein Institute for Medical Research team led by immunologist and Professor Betty Diamond has developed a system for identifying a person’s risk for lupus by examining antibodies and a specific protein complex found in the blood. Ideally, scientists may use these unique markers to…


NIH pumps $3M into Feinstein autism study

The National Institutes of Health will fund a two-year Feinstein Institute for Medical Research study exploring risk factors behind autism spectrum disorders in newborns. A $3 million NIH grant has been awarded to MDs Betty Diamond and Peter Gregersen, researchers in the Northwell Health System’s Manhasset-based R&D division, specifically to explore the relationship between a mother’s autoimmunity during pregnancy and the risk of ASD in her child. The researchers are following up previous studies in…